The effect of biological therapies on cancer risk in Jia is controversial owing to confounding factors such as the use of concomitant immunosuppressants. a study has shed new light on this association, but questions still remain on the effect of the disease itself and biological therapies on cancer risk.
The effect of biological therapies on cancer risk in JIA is controversial owing to confounding factors such as the use of concomitant immunosuppressants. A study has shed new light on this association, but questions still remain on the effect of the disease itself and biological therapies on cancer risk.
Ruperto, N., Martini, A. (2011). Pediatric rheumatology: JIA, treatment and possible risk of malignancies. NATURE REVIEWS. RHEUMATOLOGY, 7(1), 6-7 [10.1038/nrrheum.2010.199].
Pediatric rheumatology: JIA, treatment and possible risk of malignancies
Ruperto N;
2011
Abstract
The effect of biological therapies on cancer risk in Jia is controversial owing to confounding factors such as the use of concomitant immunosuppressants. a study has shed new light on this association, but questions still remain on the effect of the disease itself and biological therapies on cancer risk.
| File | Dimensione | Formato | |
|---|---|---|---|
|
2011_FPhar-JIA treatment.pdf
Solo gestori archivio
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Tutti i diritti riservati
Dimensione
302.79 kB
Formato
Adobe PDF
|
302.79 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
